Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Burn

Showing results (61-70 of 162) with videos related to

Pageof 17
Sort By:
Familial Cancer|October 9, 2008
High risk of endometrial cancer in colorectal cancer kindred is pathognomonic for MMR-mutation carriersEli Marie Grindedal, Ignacio Blanco, Astrid Stormorken, et al.
Molecular Genetics and Metabolism|April 3, 2004
Low erythrocyte folate status and polymorphic variation in folate-related genes are associated with risk of neural tube defect pregnancyCaroline L Relton, Craig S Wilding, Alison J Laffling, et al.
Trials|March 9, 2017
Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours: study protocol for a randomised controlled trialAmy Cranston, Deborah D Stocken, Elaine Stamp, et al.
European Journal of Human Genetics : EJHG|June 16, 2018
Cancer prevention by aspirin in children with Constitutional Mismatch Repair Deficiency (CMMRD)Erika K S M Leenders, Harm Westdorp, Roger J Brüggemann, et al.
Journal of the American Academy of Dermatology|May 16, 2019
Diverse presentations of cutaneous mosaicism occur in CYLD cutaneous syndrome and may result in parent-to-child transmissionMajid Arefi, Valerie Wilson, Siobhan Muthiah, et al.
Annals of Human Genetics|September 24, 2010
MLH1 Differential allelic expression in mutation carriers and controlsMauro Santibanez Koref, Valerie Wilson, Nicola Cartwright, et al.
International Journal of Cancer|February 10, 2018
Three molecular pathways model colorectal carcinogenesis in Lynch syndromeAysel Ahadova, Richard Gallon, Johannes Gebert, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 4, 2017
Aspirin-Induced Chemoprevention and Response Kinetics Are Enhanced by PIK3CA Mutations in Colorectal Cancer CellsTimothy J Zumwalt, Dominik Wodarz, Natalia L Komarova, et al.
Clinical and Experimental Dermatology|January 23, 2025
Novel microsatellite instability test of sebaceous tumours to facilitate low-cost universal screening for Lynch syndromeRichard Gallon, Georgie Holt, Waleed Alfailakawi, et al.
The Lancet. Oncology|May 5, 2009
Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statementJack Cuzick, Florian Otto, John A Baron, et al.
Pageof 17

Showing results (61-70 of 162) with videos related to

Sort By:
Pageof 17
Familial Cancer|October 9, 2008
High risk of endometrial cancer in colorectal cancer kindred is pathognomonic for MMR-mutation carriersEli Marie Grindedal, Ignacio Blanco, Astrid Stormorken, et al.
Molecular Genetics and Metabolism|April 3, 2004
Low erythrocyte folate status and polymorphic variation in folate-related genes are associated with risk of neural tube defect pregnancyCaroline L Relton, Craig S Wilding, Alison J Laffling, et al.
Trials|March 9, 2017
Tropomyosin Receptor Antagonism in Cylindromatosis (TRAC), an early phase trial of a topical tropomyosin kinase inhibitor as a treatment for inherited CYLD defective skin tumours: study protocol for a randomised controlled trialAmy Cranston, Deborah D Stocken, Elaine Stamp, et al.
European Journal of Human Genetics : EJHG|June 16, 2018
Cancer prevention by aspirin in children with Constitutional Mismatch Repair Deficiency (CMMRD)Erika K S M Leenders, Harm Westdorp, Roger J Brüggemann, et al.
Journal of the American Academy of Dermatology|May 16, 2019
Diverse presentations of cutaneous mosaicism occur in CYLD cutaneous syndrome and may result in parent-to-child transmissionMajid Arefi, Valerie Wilson, Siobhan Muthiah, et al.
Annals of Human Genetics|September 24, 2010
MLH1 Differential allelic expression in mutation carriers and controlsMauro Santibanez Koref, Valerie Wilson, Nicola Cartwright, et al.
International Journal of Cancer|February 10, 2018
Three molecular pathways model colorectal carcinogenesis in Lynch syndromeAysel Ahadova, Richard Gallon, Johannes Gebert, et al.
Cancer Prevention Research (Philadelphia, Pa.)|February 4, 2017
Aspirin-Induced Chemoprevention and Response Kinetics Are Enhanced by PIK3CA Mutations in Colorectal Cancer CellsTimothy J Zumwalt, Dominik Wodarz, Natalia L Komarova, et al.
Clinical and Experimental Dermatology|January 23, 2025
Novel microsatellite instability test of sebaceous tumours to facilitate low-cost universal screening for Lynch syndromeRichard Gallon, Georgie Holt, Waleed Alfailakawi, et al.
The Lancet. Oncology|May 5, 2009
Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statementJack Cuzick, Florian Otto, John A Baron, et al.
Pageof 17